Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Viatris Inc. VTRS

Healthcare  —  Drug Manufacturers Specialty & Generic
17.83 0.41 2.35% as of 25 Sep
Market cap
$20.0B
P/E
0.0×
S&P 500 Member Dividend Champion (5y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Viatris Inc. (VTRS) EV/EBITDA

As of 25 September 2026, Viatris Inc. (VTRS) trades at a EV/EBITDA of 12.2×. Over the past ten years it has ranged from 6.3× (March 2023) to 22.0× (April 2015); the current reading is higher than 76% of that period. That is in line with the Drug Manufacturers Specialty & Generic industry median of 12.3× and above the Healthcare sector median of 10.4×.

EV/EBITDA, daily

Annual

Period EV/EBITDA Change
FY2025 9.0× (3.55%)
FY2024 9.3× 23.86%
FY2023 7.5× 10.04%
FY2022 6.9× (20.90%)
FY2021 8.7× (55.17%)
FY2020 19.3× 124.15%
FY2019 8.6× (5.73%)
FY2018 9.1× (23.39%)
FY2017 11.9× (26.25%)
FY2016 16.2× 27.39%

Quarterly

Period EV/EBITDA Change
Jun 2026 11.4× 19.32%
Mar 2026 9.5× 5.99%
Dec 2025 9.0× 2.91%
Sep 2025 8.8× 3.24%
42 more quarters

Against its own ten years

Low 6.3× High 22.0×
Ten-year median 9.4×
Current reading's percentile 76

EV/EBITDA against peers

Company EV/EBITDA
HIMS Hims & Hers Health, Inc. compare n/m
ZTS Zoetis Inc. compare 9.6×
UTHR United Therapeutics Corporation compare 12.0×
VTRS Viatris Inc. 12.2×
HLN Haleon PLC Sponsored ADR compare 12.4×
RDY Dr. Reddy's Laboratories Ltd compare 15.9×
NBIX Neurocrine Biosciences, Inc. compare 16.7×
ELAN Elanco Animal Health Incorporated compare 18.8×
TEVA Teva Pharmaceutical Industries Ltd. compare 23.4×
Drug Manufacturers Specialty & Generic industry median 12.3×
Healthcare sector median 10.4×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on VTRS